Olorunseun Ogunwobi, MD

External Advisory Board

Dr. Olorunseun Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, USA, and a PhD in molecular medicine from the University of East Anglia, Norwich, United Kingdom. He is the founding Director of the Hunter College Center for Cancer Health Disparities Research, tenured Associate Professor of Biological Sciences at Hunter College of The City University of New York, and a member of faculty in the Biology and Biochemistry PhD programs at The Graduate Center of The City University of New York. Dr. Ogunwobi is a translational cancer biologist whose work focuses on molecular mechanisms of progression of solid organ cancers with established racial disparities, such as prostate cancer. His laboratory has established novel circulating tumor cell models that are being used progressively to elucidate molecular mechanisms underlying the role of circulating tumor cells in cancer metastasis. A major focus of Dr. Ogunwobi’s laboratory are studies elucidating the role of non-coding RNAs derived from the PVT1 gene locus in the development and progression of solid organ cancers such as prostate cancer. His work has been funded by the National Institutes of Health, New York State, Carnegie Corporation of New York, and the National Science Foundation, among others. Dr. Ogunwobi is a Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants (CA221704 and CA221705), Contact Principal Investigator of 3U54CA221704-03S1 and Co-Investigator on R01 grant CA239603 from the National Cancer Institute. An author of over 60 peer-reviewed journal articles and 2 book chapters, Dr. Ogunwobi has been issued 4 United States patents for biotechnology inventions with potential clinical applications in cancer, and he is a Co-Founder of NucleoBio, Inc, a City University of New York start-up biotechnology company.